| 000 | 01015 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517204038.0 | ||
| 264 | 0 | _c20180907 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1464-3391 | ||
| 024 | 7 |
_a10.1016/j.bmc.2018.02.046 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKennedy, Eileen J | |
| 245 | 0 | 0 |
_aConstrained peptides and biological targets. _h[electronic resource] |
| 260 |
_bBioorganic & medicinal chemistry _c03 2018 |
||
| 300 |
_a1117 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 | _aCyclization |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPeptides _xchemical synthesis |
| 650 | 0 | 4 |
_aPhosphoprotein Phosphatases _xchemistry |
| 650 | 0 | 4 |
_aReceptors, Opioid, kappa _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 773 | 0 |
_tBioorganic & medicinal chemistry _gvol. 26 _gno. 6 _gp. 1117 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bmc.2018.02.046 _zAvailable from publisher's website |
| 999 |
_c28159868 _d28159868 |
||